3//SEC Filing
EcoR1 Panacea Holdings, LLC 3
Accession 0001213900-20-016361
CIK 0001811063other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:02 PM ET
Size
16.5 KB
Accession
0001213900-20-016361
Insider Transaction Report
Form 3
EcoR1 Panacea Holdings, LLC
Director10% Owner
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
NODELMAN OLEG
DirectorCEO and Chairman of the Board
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
EcoR1 Capital Fund Qualified, L.P.
Director10% Owner
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
EcoR1 Capital Fund, L.P.
Director10% Owner
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
EcoR1 Venture Opportunity Fund, LP
Director10% Owner
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
EcoR1 Capital, LLC
Director10% Owner
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
Biotech Opportunity GP, LLC
Director10% Owner
Holdings
Class B common stock
→ Class A common stock (2,775,000 underlying)
Footnotes (2)
- [F1]As described in the issuer's registration statement on Form S-1 (File No. 333-239138) under the heading "Description of Securities--Founder Shares," shares of Class B common stock of the issuer, par value $0.0001 per share ("Class B Common Stock"), will automatically convert into shares of Class A common stock of the issuer, par value $0.0001 per share ("Class A Common Stock"), at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date. Includes 375,000 shares of Class B Common Stock that are subject to forfeiture if the underwriter of the issuer's initial public offering does not exercise in full its option to purchase additional units.
- [F2]The reporting owner, EcoR1 Panacea Holdings, LLC (the "Sponsor"), in whose name the securities reported herein are held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the "General Partners"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein.
Documents
Issuer
Panacea Acquisition Corp
CIK 0001811063
Entity typeother
Related Parties
1- filerCIK 0001816134
Filing Metadata
- Form type
- 3
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 6:02 PM ET
- Size
- 16.5 KB